Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
05/2010
05/25/2010US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders
05/25/2010US7722874 Methods for reducing T cell responsiveness to an autoantigen with anti-gp39 antibodies and antigen presenting cells
05/25/2010CA2584975C Drug and food or drink for improving pancreatic functions
05/25/2010CA2489337C Indole derivatives useful as histamine h3 antagonists
05/25/2010CA2469393C Processes for the measurement of the potency of glatiramer acetate
05/25/2010CA2403423C Tri-aryl-substituted-ethane pde4 inhibitors
05/25/2010CA2395461C Methods of modulating c-kit tyrosine kinase function with indolinone compounds
05/25/2010CA2376666C Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications
05/25/2010CA2375923C Devices and compounds for treating arterial restenosis
05/25/2010CA2375727C Cytofectin dimers and methods of use thereof
05/25/2010CA2354928C Non-mucin type synthetic compounds or it's carrier conjugated compounds
05/25/2010CA2322424C 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them
05/25/2010CA2321920C 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
05/25/2010CA2314156C Pyrrole substituted 2-indolinone protein kinase inhibitors
05/25/2010CA2199715C Novel implant and novel vector for the treatment of acquired diseases
05/20/2010WO2010057048A1 Therapies for hematologic malignancies
05/20/2010WO2010056144A2 Foxp3+ natural kiler t-cells and the treatment of immune related diseases
05/20/2010WO2010056143A1 The use of adjuvant to facilitate the induction of immune tolerance
05/20/2010WO2010055371A1 Medicament for inhibiting the synthesis of leukotrienes
05/20/2010WO2010055304A2 Pharmaceutical compounds
05/20/2010WO2010055117A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
05/20/2010WO2010055028A2 Organic compounds
05/20/2010WO2010055004A1 Naphthylacetic acids
05/20/2010WO2010054878A2 Hypoallergenic dermatological composition
05/20/2010WO2010036631A3 Sulfonyl compounds which selectively modulate the cb2 receptor
05/20/2010WO2010036630A3 Sulfonyl compounds which selectively modulate the cb2 receptor
05/20/2010WO2010032008A3 Dendritic cell modulatory molecule
05/20/2010WO2010027567A3 Tricyclic spirocycle derivatives and methods of use thereof
05/20/2010WO2010025321A3 Method for treating multiple sclerosis patients with anti-il2r antibodies
05/20/2010WO2010006162A3 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs
05/20/2010WO2010003002A9 Modulation of follicular helper t cells
05/20/2010WO2009050742A8 Use of microvesicles (mvs) for preparing a medicament having adjuvant activity on endothelial cell transplantation, particularly in the treatment of diabetes by pancreatic islet transplantation, and related method
05/20/2010US20100125101 Immunostimulatory nucleic acid molecules
05/20/2010US20100125080 Compounds for inflammation and immune-related uses
05/20/2010US20100125071 Cxc-chemokine receptor ligands
05/20/2010US20100125069 Methods of Treating or Preventing Autoimmune Diseases with 2,4-Pyrimidinediamine Compounds
05/20/2010US20100125061 Naphthylacetic acids
05/20/2010US20100124558 Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety
05/20/2010US20100124546 Adenovirus With Mutations in the Endoplasmic Reticulum Retention Domain of the E3-19K Protein and Their Use in Cancer Treatment
05/20/2010US20100124534 Immunotherapeutic method
05/20/2010CA2743709A1 Treatment of proteinopathies using a farnesyl transferase inhibitor
05/20/2010CA2743642A1 Therapies for hematologic malignancies
05/20/2010CA2743502A1 Foxp3+ natural killer t-cells and the treatment of immune related diseases
05/20/2010CA2743232A1 Crystalline forms of fingolimod hcl
05/20/2010CA2743073A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
05/20/2010CA2743017A1 Hypoallergenic dermatological composition
05/20/2010CA2742990A1 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
05/20/2010CA2741974A1 Salts of fingolimod
05/20/2010CA2740863A1 Naphthylacetic acids
05/20/2010CA2707026A1 Anti-human il-21 monoclonal antibodies
05/19/2010EP2186892A1 Anti-cd20 monoclonal antibodies
05/19/2010EP2186407A1 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
05/19/2010EP2185514A1 Vinyl-aryl derivatives for inflammation and immune-related uses
05/19/2010EP2185181A2 Therapeutic uses of gastrin-1 and g-pen-grgdspca
05/19/2010EP2185177A1 Use of c-type natriuretic peptide, alone or incombination with neuropeptide af, as a therapeutic agent
05/19/2010EP2185171A2 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents
05/19/2010EP2185164A1 Composition and therapeutic anti-tumour vaccine
05/19/2010EP2184994A1 Heterocycle-aryl compounds for inflammation and immune-related uses
05/19/2010EP2184988A1 Small molecule inhibitors of lck sh2 domain binding
05/19/2010EP1485380B1 Azolylaminoazines as inhibitors of protein kinases
05/19/2010EP1467995B1 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
05/19/2010EP1371646B1 Aryl-substituted alicyclic compound and medical composition comprising the same
05/19/2010EP1292671B9 Method for obtaining characterised muscle-derived cell populations and uses
05/19/2010EP1180991B1 Gambogic acid derivatives as activators of caspases and inducers of apoptosis
05/19/2010CN1973651B Vanilla-asiatic centella tea and its preparation process
05/19/2010CN101711253A Novel compounds as cannabinoid receptor ligands
05/19/2010CN101709078A immune-modulating peptide
05/19/2010CN101708333A Multivalent vaccine composition
05/19/2010CN101708330A Antibody-containing chicken egg protein injection for controlling swine fever (diseases)
05/19/2010CN101708328A Pharmaceutical application of CYR61 protein
05/19/2010CN101708286A Chinese patent medicament for treating sjogren's syndrome and intractable oral ulcer, and preparation method thereof
05/19/2010CN101708247A Compound antivirus immune intensifier of Chinese herbal medicine
05/19/2010CN101708215A Method for extracting triterpenes from schisandra chinansis
05/19/2010CN101708193A Pharmaceutical composition of triptolide-containing medicine and bracken and preparation and application thereof
05/19/2010CN101708178A Compound sustained-release tablet of cetirizine and pseudoephedrine and preparation method thereof
05/19/2010CN101124945B Special-purpose traditional Chinese medicinal composition for fresh water fish infectious diseases
05/19/2010CN101103036B Artemisine (Qinghaosu) derivatives, their preparation methods and their use, and pharmaceutical compositions containing the same
05/19/2010CN101095708B Use of bupleurum root total polyoses in the preparing of medicine for preventing and treating systematic lupus erythematosus
05/19/2010CN101095701B Flaky medicine containing Hirsutella hepiali - cordyceps fungus powder and method for preparing the same
05/19/2010CN101049320B Buccal tablets of extractive of propolis alcohol
05/19/2010CN101044884B Method for prepairng feed additives containing yolk anti body
05/19/2010CN101040928B Treatment type ganoerma lucidum compound tea
05/19/2010CN101040912B Chinese traditional medicine capsule preparation for resisting radiation and improving immunity, and the method for preparing the same
05/19/2010CN101040891B Method of preparing tripterygium hypoglaucum (Levl) hutch alkaloids
05/19/2010CN101040848B Method for preparing amphiphilic nanoparticles
05/19/2010CN101036698B Mulberry leaf extract and its preparing process and application
05/19/2010CN101036691B Health-caring product for improving bone density and immunity
05/19/2010CN101032620B Cyclosporine emulsion and the preparing method
05/19/2010CN101028461B Job's tears nut oil self-emusifying preparation and its making method
05/19/2010CN101028441B Energy-supplemented liquid health-care medicinal liquor
05/19/2010CN101028427B Chinese-medicinal decoction for treating hives
05/19/2010CN101028372B Chinese medicinal decoction for treating hives
05/19/2010CN101011531B Medicine for treating children's anorexia and repetitive infection and its preparing method
05/19/2010CN101011176B Healthy drink for reinforcing stomach and building a healthy body and production method thereof
05/19/2010CN100998693B Health-care medicated wine made of traditional Chinese medicines
05/19/2010CN100998592B Microemulsion containing matrine
05/18/2010US7718777 MHC-peptide complex binding ligands
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718701 Prostaglandin, e.g., 1R,2R,3R,5R)-5-halo-2-[(1E,3S)-3-cycloalkyl-3-hydroxy-1-propenyl]-3-hydroxycyclopentyl]-(5Z)-5-alkenoic acids; treating in particular, symptoms of atopic dermatitis
05/18/2010US7718662 Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
1 ... 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 ... 1172